Monitoring respiratory parameters through ultrasonic measurements indicating flow changes in respiratory drug delivery devices
US-2016166787-A1 · Jun 16, 2016 · US
US12364824B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12364824-B2 |
| Application number | US-202117156080-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 22, 2021 |
| Priority date | Aug 28, 2014 |
| Publication date | Jul 22, 2025 |
| Grant date | Jul 22, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A compliance monitoring module for a breath-actuated inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being pneumatically coupled to a flow channel through which a user can inhale; a processor configured to: receive a signal originating from a dosing mechanism of the inhaler indicating that medication has been released; receive data from a sensing element of the sensor; and based on said signal from said dosing mechanism and said data from said sensing element, make a determination that inhalation of a breath containing medication through said flow channel complies with one or more predetermined requirements for successful dosing; and a transmitter configured to, responsive to said determination, issue a dosing report.
Opening claim text (preview).
What is claimed is: 1. An inhaler comprising: a flow channel through which a user can inhale; a mouthpiece cover configured to make a bolus of dry powder medicament available to the flow channel prior to the user inhaling therethrough in response to the mouthpiece cover moving to expose a mouthpiece of the inhaler; a compliance monitoring module comprising a pressure sensor and a processor, wherein the processor is configured to: receive a signal indicating that the bolus of dry powder medicament is available to the flow channel; receive data from the pressure sensor; and based on the signal indicating that the bolus of dry powder medicament is available to the flow channel and the data from the pressure sensor, determine that inhalation of a breath containing medicament through the flow channel complies with one or more predetermined requirements for successful dosing. 2. The inhaler of claim 1 , wherein the processor is adapted to determine a flow rate in the flow channel based on the data from the pressure sensor; and wherein the processor is configured to determine that the inhalation of a breath containing medicament through the flow channel complies with one or more predetermined requirements for successful dosing when: the flow rate exceeds a predetermined threshold value; an inhalation duration exceeds a predetermined threshold value; the flow rate exceeds a predetermined threshold value for at least a predetermined threshold duration; or a total volume inhaled exceeds a predetermined threshold value. 3. The inhaler of claim 1 , further comprising a hopper and a dosing chamber, wherein the inhaler is configured to meter said bolus of dry powder medicament from the hopper to the dosing chamber. 4. The inhaler of claim 1 , wherein the compliance monitoring module is configured to be affixed to the part of a main body of a housing of the inhaler that is uppermost in use. 5. The inhaler of claim 1 , further comprising: a first housing that comprises the dry powder medicament; and a second housing mechanically coupled to the first housing, wherein the second housing includes the pressure sensor and the processor. 6. The inhaler of claim 1 , wherein the pressure sensor comprises a microelectromechanical system (MEMS) pressure sensor or a nanoelectromechanical system (NEMS) pressure sensor. 7. The inhaler of claim 1 , wherein the pressure sensor comprises a barometric pressure sensor that is configured to measure a barometric pressure change outside of the flow channel resulting from an inhalation or an exhalation into a mouthpiece of the inhaler. 8. The inhaler of claim 1 , wherein the pressure sensor is located external to the flow channel and a sensor port of the inhaler is pneumatically coupled to the flow channel via an opening in a wall of the flow channel. 9. The inhaler of claim 8 , further comprising a seal arranged to pneumatically couple the sensor port to the opening. 10. The inhaler of claim 9 , wherein at least a part of said seal is sandwiched between the pressure sensor and the wall, at least a part of said seal extending from an exterior surface of said wall to a surface on which the pressure sensor is mounted so as to encapsulate the pressure sensor in a pneumatic chamber adjacent the wall. 11. The inhaler of claim 9 , further comprising a thermally conductive gasket sandwiched between the pressure sensor and the wall, the thermally conductive gasket configured as the seal. 12. The inhaler of claim 1 , wherein the compliance monitoring module comprises a wireless transmitter configured to, responsive to the determination, issue a dosing report. 13. The inhaler of claim 1 , wherein the compliance monitoring module is configured to be removed from and attached to the inhaler. 14. The inhaler of claim 1 , further comprising a switch that is configured to be actuated when the bolus of dry powder medicament is available to the flow channel; and wherein the processor is configured to receive an electronic pulse from the switch when the bolus of dry powder medicament is available to the flow channel. 15. The inhaler of claim 14 , wherein the switch is configured to be actuated when the mouthpiece cover is moved to expose the mouthpiece. 16. The inhaler of claim 14 , further comprising a yoke that is coupled to the mouthpiece cover, and is configured to move to actuate the switch when the mouthpiece cover is moved to expose the mouthpiece. 17. The inhaler of claim 1 , wherein the dry-powder medicament comprises an asthma medication or chronic obstructive pulmonary disease (COPD) medication.
having a display or indicator · CPC title
using modem, internet or Bluetooth® · CPC title
having a color code · CPC title
with non implanted data transmission devices, e.g. using external transmitter or receiver · CPC title
Pressure; Flow · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.